drugset / Trial / NCT06660810
Neoadjuvant Intralesional Injection of Talimogene Laherparepvec
NaSingle-groupOpen-labelTreatment
Summary
The proposed study is designed to treat locally advanced soft tissue sarcoma (STS) subtypes with neoadjuvant talimogene laherparepvec (TVEC) and preoperative external beam radiation therapy (EBRT).
Timeline
- Start
- 2025-03-03
- Primary completion
- 2026-05-26
- Completion
- 2031-02-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Talimogene Laherparepvec | Other / unclassified | — | Other |